Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11% Steroid Cream----[1] 13
2Antituberculous therapy along with steroids----[1] 84
3Bilateral transforaminal epidural steroid injections----[1] 70
4Combination Steroid----[1] 46
5Cyclophosphamide and steroids[1] Cyclophosphamide[2] D00287 ,
D07760
--[1] 222
6Cyclosporin, low dose steroid[1] Cyclosporine[1] D00184 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222
7Epidural Steroid Injection----[1] 70
8Intra-articular steroid injection----[1] 107
9Intravenous steroid----[1] 13
10IV methylprednisolone (steroids)[1] Methylprednisolone[1] D00407 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
11Mycophenolate mofetil, low dose steroid[2] Mycophenolate mofetil,
Mycophenolic acid
[2] D00752 ,
D05096
[2] IMPDH1,
IMPDH2 💬
[4] Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬[1] 222
12Myfortic plus low-dose steroid[1] Mycophenolic acid[1] D05096 [2] IMPDH1,
IMPDH2 💬
[4] Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬[1] 222
13Non-steroidal anti-inflammatory drug----[1] 46
14Non-steroidal anti-inflammatory drug (NSAID)----[1] 46
15Non-steroidal anti-inflammatory drugs----[1] 46
16Non-steroidal anti-inflammatory drugs (NSAIDs)----[1] 107
17Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac[1] Etodolac[1] D00315 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
18Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses----[1] 46
19Routine steroid administration group----[1] 85
20Standard Steroid Treatment----[1] 85
21Steroid----[2] 107, 288
22Steroid & Cyclosporin[1] Cyclosporine[1] D00184 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222
23Steroid and Proton Pump Inhibitor Therapy----[1] 98
24Steroid Drug----[2] 46, 49
25Steroid injections----[1] 70
26Steroid Taper----[1] 49
27Steroids----[7] 46, 50, 51, 63, 66, 96, 97
28Steroids plus azathioprine[1] Azathioprine[1] D00238 --[1] 66
29Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)[1] Human immunoglobulin G---[1] 11
30The Standard Steroid Treatment, Plasma Exchange and rituximab[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 85
31Tocilizumab and IV steroids combination[1] Tocilizumab[1] D02596 [1] IL6R 💬[12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 41